Company Overview of Autifony Therapeutics Limited
Autifony Therapeutics Limited, a biotechnology company, develops medicines to treat hearing disorders such as hearing loss and tinnitus. The company was incorporated in 2011 and is based in London, United Kingdom.
90 High Holborn
London, WC1V 6XX
Founded in 2011
Key Executives for Autifony Therapeutics Limited
Co-Founder and Head of Preclinical Drug Discovery
Compensation as of Fiscal Year 2015.
Autifony Therapeutics Limited Key Developments
Autifony Therapeutics Announces Executive Changes
Sep 3 15
Autifony Therapeutics announced that Dr. John Hutchison has joined the company as Chief Medical Officer. Previously, Dr. Hutchison was Chief Medical Officer and VP of Clinical Research at Pfizer Neusentis in the UK. He will lead Autifony’s growing clinical development team that will oversee the evaluation of two different candidate drugs in multiple clinical trials by the end of the year. Dr. Hutchinson joins ahead of the retirement of Dr. Peter Harris at the end of September 2015.
Autifony Therapeutics Limited Presents at 22nd Annual NewsMakers in the Biotech Industry Investment Conference, Sep-10-2015 02:00 PM
Aug 8 15
Autifony Therapeutics Limited Presents at 22nd Annual NewsMakers in the Biotech Industry Investment Conference, Sep-10-2015 02:00 PM. Venue: Millennium Broadway Hotel & Conference Center - Breakout Room 401, 145 West 44th Street, New York, New York, United States.
Autifony Therapeutics Limited Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-29-2015 through Sep-30-2015
Jul 30 15
Autifony Therapeutics Limited Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-29-2015 through Sep-30-2015. Venue: Congress Center, Basel, Switzerland. Presentation Date & Speakers: Sep-29-2015, Barbara Domayne-Hayman, CBO.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries